Universe Pharmaceuticals (UPC) Assets Average (2021 - 2025)
Universe Pharmaceuticals (UPC) reported Assets Average of $68.6 billion for Q3 2025, up 101.84% on a YoY basis from $34.0 billion in Q3 2024, and up 101.84% sequentially from $34.0 billion in Q3 2024.
Universe Pharmaceuticals (UPC) Assets Average (2021 - 2025) Analysis & Trends
Universe Pharmaceuticals (UPC) has 5 years of Assets Average data on file, last reported at $68.6 billion in Q3 2025.
- For the quarter ending Q3 2025, Assets Average rose 101.84% year-over-year to $68.6 billion; the trailing twelve-month figure through Sep 2025 stood at $68.6 billion (up 101.84% YoY), and the FY2025 full-year result was $68.6 billion, up 101.86% from the prior year.
- Assets Average advanced to $68.6 billion in Q3 2025, from $34.0 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $68.6 billion in Q3 2025 to a low of $35.1 million in Q3 2021.
- A 5-year average of $12.9 billion and a median of $65.2 million in 2022 frame the typical range for Assets Average.
- Peak annual rise in Assets Average reached 60566.53% in 2024, while the deepest fall reached 29.83% in 2024.
- Tracing UPC's Assets Average over 5 years: stood at $35.1 million in 2021, then soared by 86.62% to $65.5 million in 2022, then declined by 14.37% to $56.0 million in 2023, then soared by 60566.53% to $34.0 billion in 2024, then jumped by 101.84% to $68.6 billion in 2025.
- Business Quant data shows UPC's Assets Average at $68.6 billion in Q3 2025, $34.0 billion in Q3 2024, and $45.6 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 873.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 68.63 Bn |
| Sep 30, 2024 | 34.00 Bn |
| Mar 31, 2024 | 45.58 Mn |
| Sep 30, 2023 | 56.05 Mn |
| Mar 31, 2023 | 64.95 Mn |
| Sep 30, 2022 | 65.45 Mn |
| Mar 31, 2022 | 70.76 Mn |
| Sep 30, 2021 | 35.07 Mn |